7521-70-2

Basic information

• Product Name: C-QUINOLIN-3-YL-METHYLAMINE
• Synonyms: C-QUINOLIN-3-YL-METHYLAMINE;QUINOLIN-3-YLMETHYL-AMINE;TIMTEC-BB SBB010402;RARECHEM AL BW 2146;1-quinolin-3-ylmethanamine;3-Quinolinemethanamine;(quinolin-3-ylmethyl)amine(SALTDATA: 2HCl);3-quinolinylmethanamine
• CAS NO: 7521-70-2
• Molecular Formula: C₁₀H₁₀N₂
• Molecular Weight: 158.2
• EINECS: 604-604-1
• Mol File: 7521-70-2.mol

Chemical Properties

• Boiling Point: 310°C at 760 mmHg
• Flash Point: 166.9°C
• Appearance: /
• Density: 1.156g/cm³
• Vapor Pressure: 0.000615mmHg at 25°C
• Refractive Index: 1.662
• Storage Temp.: 2-8°C(protect from light)
• PKA: 8.34±0.29(Predicted)
• CAS DataBase Reference: C-QUINOLIN-3-YL-METHYLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: C-QUINOLIN-3-YL-METHYLAMINE(7521-70-2)
• EPA Substance Registry System: C-QUINOLIN-3-YL-METHYLAMINE(7521-70-2)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• HazardClass: IRRITANT
• Hazardous Substances Data: 7521-70-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
C-QUINOLIN-3-YL-METHYLAMINE is used as an intermediate or building block for the synthesis of pharmaceuticals, contributing to the development of new drugs and materials. Its unique chemical structure allows it to be a versatile component in the creation of various medicinal compounds.
Used in Agrochemical Industry:
In the agrochemical sector, C-QUINOLIN-3-YL-METHYLAMINE serves as a key intermediate in the synthesis of agrochemicals, playing a crucial role in the development of new pesticides and other agricultural products to enhance crop protection and yield.
Used in Organic Synthesis:
C-QUINOLIN-3-YL-METHYLAMINE is utilized as a building block in organic synthesis, enabling the creation of a wide range of organic compounds for various applications, from specialty chemicals to advanced materials.
Used in Drug Discovery:
Due to its potential applications in the development of new drugs, C-QUINOLIN-3-YL-METHYLAMINE is the subject of ongoing research in pharmaceutical science. Its unique properties make it a promising candidate for the discovery of novel therapeutic agents.
Overall, C-QUINOLIN-3-YL-METHYLAMINE's diverse applications across different industries highlight its importance and versatility in the fields of chemistry and pharmaceutical science.

InChI:InChI=1/C10H10N2/c11-6-8-5-9-3-1-2-4-10(9)12-7-8/h1-5,7H,6,11H2

Upstream product

• 1133256-83-3 2-(quinolin-3-ylmethyl)isoindoline-1,3-dione 
• 34846-64-5 3-cyanoquinoline 
• 120277-70-5 3-(bromomethyl)quinoline 
• 612-58-8 3-methylquinoline 
• 13669-51-7 3-Hydroxymethylquinoline 
• 13669-42-6 3-quinolylcarboxaldehyde 
• 7732-18-5 water 
• 593-56-6 N-methoxylamine hydrochloride 
• 7440-66-6 zinc 
• 39977-73-6 quinoline-3-carbaldehyde oxime 

Relevant articles and documents

P2X3 AND/OR P2X2/3 COMPOUNDS AND METHODS

The present disclosure provides novel compounds and methods for preparing and using these compounds. In one embodiment, the compounds are of the structure of formula (I), wherein R1-R7 are defined herein. In a further embodiment, these compounds are useful in method for regulating one or both of the P2X3 or P2X2/3 receptors. In another embodiment, these compounds are useful for treating pain in patients by administering one or more of the compounds to a patient. In another embodiment, these compounds are useful for treating respiratory dysfunction in patients by administering one or more of the compounds to a patient.

COMPOUNDS AND METHODS FOR TREATMENT OF CANCER BY INHIBITING ATG4B AND BLOCKING AUTOPHAGY

ATG4B inhibitor compounds, compositions that include the compounds, and methods for using the compounds and compositions in the treatment of cancer by inhibiting ATG4B and/or blocking autophagy.

6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY

PROBLEM TO BE SOLVED: To provide 6-O-substituted ketolides with antibacterial activity, having acid stability and enhanced activity toward gram negative bacteria and macrolide resistant gram positive bacteria. SOLUTION: This invention provides 6-O-substituted erythromycin ketolide derivatives such as formula (II) and compositions comprising the compounds. [Y and Z together form a group X; X is ketone, hydroxyimino or the like; or, one of Y and Z is H and the other is hydrogen, hydroxy or the like; Ra is H, hydroxy; Rc is H or a hydroxy protective group; R is a substituted methyl group]. COPYRIGHT: (C)2015,JPOandINPIT

Peptide deformylase inhibitors

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhibition of bacterial peptide deformylase (PDF) activity.

PEPTIDE DEFORMYLASE INHIBITORS

The present invention relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods directed to bacterial infections and inhi-bition of bacterial peptide deformylase (PDF) activity

Design, synthesis, and biological activities of novel 2-cyanoacrylates containing oxazole, oxadiazole, or quinoline moieties

A series of novel 2-cyanoacrylates containing an oxazole, oxadiazole, or quinoline moiety were designed and synthesized, and their structures were characterized by 1H NMR and elemental analysis (or high-resolution mass spectrometry). Their herbicidal activities against four weeds were evaluated, and the result indicated that some of the title compounds showed excellent herbicidal activities against rape and amaranth pigweed in postemergence treatment at a dose of 375 g/ha. Furthermore, most of these cyanoacrylates exhibited interesting plant growth regulatory activities.

7-Substituted Purine Derivatives for Immunosuppression

The present invention provides novel purinone and related derivatives useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection. The compounds are of the general formula III:

Calcilytic compounds and method of use

Calcilytic compounds and compositions and their use in treating abnormal bone or mineral homeostasis.

6-O-substituted ketolides having antibacterial activity

Antimicrobial compounds having the formula STR1 as well as pharmaceutically acceptable salts, esters or prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds.